357 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Not yet recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Not yet recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
5 Recruiting Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Progesterone;   Drug: Placebo
6 Recruiting INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Pegylated Lipoxomal Doxorubicin (PLD);   Drug: Trabectedin
7 Recruiting Prophylactic Salpingectomy With Delayed Oophorectomy
Condition: Ovarian Carcinoma
Interventions: Other: Ovarian Cancer Screening;   Procedure: Prophylactic Salpingectomy with Delayed Oophorectomy;   Procedure: Risk-Reducing Salpingo-Oophorectomy;   Behavioral: Questionnaire;   Procedure: Transvaginal Ultrasound;   Behavioral: Phone Call
8 Not yet recruiting Liver and Fat Regulation in Overweight Adolescent Girls
Conditions: Hepatic Steatosis;   Polycystic Ovarian Syndrome;   Obesity
Intervention:
9 Recruiting A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Condition: Platinum Sensitive Ovarian Cancer
Interventions: Drug: Active comparator: Niraparib;   Drug: placebo
10 Recruiting Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.
Conditions: Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:
11 Recruiting Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence
Condition: First Recurrence of Ovarian Cancer
Interventions: Procedure: Secondary citoreduction;   Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)
12 Recruiting Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Brenner Tumor;   Malignant Ascites;   Malignant Pleural Effusion;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: docetaxel;   Drug: metformin hydrochloride;   Drug: placebo;   Other: laboratory biomarker analysis
13 Recruiting Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
14 Recruiting An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Intervention:
15 Unknown  Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: clomiphene citrate;   Drug: raloxifene
16 Recruiting Vitamin D Status in Relation to Insulin Sensitivity Among Saudi Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Dietary Supplement: Vitamin D3 pills;   Other: Placebo pills
17 Recruiting Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
Condition: Ovarian Hyperstimulation Syndrome
Intervention: Drug: recombinant LH
18 Unknown  A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Lovastatin and Paclitaxel
19 Recruiting Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Letrozole;   Drug: Chinese herbal medicine granules or Chinese herbal medicine granules placebo
20 Recruiting p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Condition: Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Interventions: Drug: APR-246;   Drug: Carboplatin;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride (PLD)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years